ARTIVA BIOTHERAPEUTICS INC. - COMMON STOCK
1.9700
03-六月-25 07:06:09
15 分钟延时
股票
+0.0300
+1.55%
今日范围
1.8900 - 1.9700
ISIN
N/A
来源
NASDAQ
-
Artiva Biotherapeutics to Participate in the Jefferies Global Healthcare Conference
28 5月 2025 13:05:00 条件 Nasdaq GlobeNewswire
-
Artiva Biotherapeutics Reports First Quarter 2025 Financial Results, Recent Business Highlights
08 5月 2025 05:00:00 条件 Nasdaq GlobeNewswire
-
Artiva Biotherapeutics Appoints Subhashis Banerjee, M.D., as Chief Medical Officer
08 4月 2025 13:05:00 条件 Nasdaq GlobeNewswire
-
Artiva Biotherapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
31 3月 2025 13:05:00 条件 Nasdaq GlobeNewswire
-
Artiva Biotherapeutics Reports Full Year 2024 Financial Results and Recent Business Highlights
24 3月 2025 13:05:00 条件 Nasdaq GlobeNewswire
-
Artiva Biotherapeutics to Participate in the TD Cowen 45th Annual Health Care Conference
20 2月 2025 13:05:00 条件 Nasdaq GlobeNewswire
-
Artiva Biotherapeutics Expands Board of Directors with Appointment of Dan Baker, M.D.
29 1月 2025 13:05:00 条件 Nasdaq GlobeNewswire
-
Artiva Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
12 11月 2024 13:05:01 条件 Nasdaq GlobeNewswire
-
Artiva Biotherapeutics to Participate in the Jefferies London Healthcare Conference
11 11月 2024 13:05:00 条件 Nasdaq GlobeNewswire
-
Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors
22 10月 2024 13:05:00 条件 Nasdaq GlobeNewswire
-
Artiva Biotherapeutics to Participate in the 2024 Cantor Fitzgerald Global Healthcare Conference
10 9月 2024 13:05:00 条件 Nasdaq GlobeNewswire
-
Artiva Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
29 8月 2024 13:05:00 条件 Nasdaq GlobeNewswire
-
Artiva Biotherapeutics Announces Pricing of Upsized $167.0 Million Initial Public Offering
18 7月 2024 16:08:52 条件 Nasdaq GlobeNewswire
- <<
- <
- 1
- >